We are monitoring the impact of COVID-19 & Recession alarm on APAC Viral Inactivation Market Get in touch with us for detailed analysis Know More
Share on

Asia Pacific Viral Inactivation Market Research Report - Segmented By Method, Product, Application, End User & Country (India, China, Japan, South Korea, Australia, New Zealand, Thailand, Malaysia, Vietnam, Philippines, Indonesia, Singapore & Rest of APAC) - Industry Analysis, Size, Share, Growth, Trends, & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3101
Pages: 140

Asia Pacific Viral Inactivation Market Size & Growth (2022 to 2027)

As per the research report, the size of the Asia Pacific Viral Inactivation Market was valued at USD 108.22 million in 2022 and estimated to be growing at a CAGR of 13.6%, to reach USD 204.73 million by 2027 during the forecast period 2022 to 2027.

One of the primary reasons driving the APAC Viral Inactivation market is the rising prevalence of infectious diseases. Furthermore, numerous government programmers to update healthcare infrastructure in various nations are fueling market expansion.

Other reasons, such as the continuous release of new medications and therapeutic goods, intensive research and development (R&D) operations, and growing consumer awareness of the transmission of blood-borne viruses via plasma, are all helping to boost the market.

Another important consideration is the growth of viruses and contamination from the selected biotherapeutic commodity during the manufacturing process; the approach is widely used in the food and blood plasma industries, where viral particles might cause problems.

To remove or inactivate potential contaminating viruses, viral inactivation is a crucial and required step in the production process of biological products. In humans, these natural products are employed for therapy and diagnosis. In addition, as the global disease burden rises, so does the need for medications, increasing the manufacturing of biologicals, injectables, and other drugs.

High costs associated with the research, manufacture, and distribution of biosimilar goods, as well as a scarcity of experienced specialists, are projected to stifle market expansion in the forecast term.

This research report on the APAC Viral Inactivation Market has been segmented and sub-segmented into the following categories:

By Method:

  • Solvent/Detergent Method
  • Pasteurization
  • UV Radiation
  • Microwave Heating
  • High-Energy Light

By Product:

  • Services
  • Kits and Reagents
  • Accessories
  • Viral Inactivation Systems

By Application:

  • Vaccines and Therapeutics
  • Stem Cell Products
  • Cell Culture
  • Gene Therapy
  • Blood & Blood Products

By End User:

  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations
  • Academic Research Institutes
  • Others

By Country:

  • India
  • China
  • Japan
  • South Korea
  • Australia
  • New Zealand
  • Thailand
  • Malaysia
  • Vietnam
  • Philippines
  • Indonesia
  • Singapore
  • Rest of APAC

Geographically, the Asia-Pacific region is the fastest-growing region worldwide, with increasing numbers of new medications and government measures influenced to drive regional market growth.

The India's viral inactivation market and China's viral inactivation market are projected to reach a decent CAGR during the forecast period. Companies focused on developing technologically advanced products in countries like India, China, and Japan due to expanding R&D investments in the life science industry and improvements in Nano filtration technology are likely to increase demand for viral clearance. In addition, rising government financing for the pharmaceutical and biotechnology industries and the development of novel pharmaceuticals are expected to be fueled over the estimated period.

The APAC Viral Inactivation Market is predicted to rise in the following years, owing to rapid growth in the pharmaceutical and biotechnology sectors, an increase in the number of new drug launches, growing government backing, and substantial R&D investments in the life sciences industry.

Increase in the frequency of chronic diseases such as diabetes, cancer, autoimmune disorders, and other conditions across the Asia Pacific has increased healthcare spending. An rise in healthcare spending is mainly required to conceive and develop new and improved therapies.

Many businesses and government agencies have made significant investments in the life sciences sector in recent years. As a result, the number of innovative and alternative medicines for treating diseases, such as stem cell therapy and cellular and gene therapy, has increased significantly. Viral inactivation is a critical technique that must follow throughout the preparation of these items to avoid contamination and fatalities after human eating.

KEY MARKET PLAYERS

Top companies leading the APAC Viral Inactivation Market profiled in the report are Clean Cells, SGS S.A, Merck KGaA, Parker Hannifin, Red Source Technologies, Sartorius AG, Charles River Laboratories International Inc., Texcell Inc., Viral Inactivated Plasma Systems SA, Danaher Corporation, and WuXi Pharma Tech Inc.,

1.Introduction         

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods 

                1.4 General Study Assumptions                

2. Research Methodology                  

                2.1 Introduction      

                2.2 Research Phases                      

       2.2.1 Secondary Research           

       2.2.2 Primary Research 

       2.2.3 Econometric Modelling      

       2.2.4 Expert Validation  

                2.3 Analysis Design

                2.4 Study Timeline 

3. Overview              

                3.1 Executive Summary                

                3.2 Key Inferences

                3.3 Epidemology     

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)           

                4.1 Market Drivers 

                4.2 Market Restraints                    

                4.3 Key Challenges

                4.4 Current Opportunities in the Market     

5. Market Segmentation                     

                5.1 Method                       

       5.1.1 Solvent/Detergent Method            

       5.1.2 Pasteurization       

       5.1.3 UV Radiation          

       5.1.4 Microwave Heating             

       5.1.5 High-Energy Light 

       5.1.6  Y-o-Y Growth Analysis, By Method              

       5.1.7  Market Attractiveness Analysis, By Method            

       5.1.8  Market Share Analysis, By Method             

                5.2 Product                        

       5.2.1 Kits and Reagents

       5.2.2 Services    

       5.2.3 Accesories               

       5.2.4 Viral Inactivation Systems 

       5.2.5 Y-o-Y Growth Analysis, By Product               

       5.2.6 Market Attractiveness Analysis, By Product             

       5.2.7 Market Share Analysis, By Product               

                5.3 Application                 

       5.3.1 Vaccines and Therapeutics               

       5.3.2 Stem Cell Products              

       5.3.3 Cell Culture             

       5.3.4 Gene Therapy       

       5.3.5 Blood & Blood Products     

       5.3.6 Y-o-Y Growth Analysis, By Application         

       5.3.7  Market Attractiveness Analysis, By Application      

       5.3.8 Market Share Analysis, By Application        

                5.4 End User                      

       5.4.1 Pharmaceutical and Biotechnology Companies       

       5.4.2 Contract Research Organizations   

       5.4.3 Academic Research Institutes         

       5.4.4 Other End Users   

       5.4.5 Y-o-Y Growth Analysis, By End User             

       5.4.6  Market Attractiveness Analysis, By End User          

       5.4.7 Market Share Analysis, By End User             

6. Geographical Analysis                     

                6.1 Introduction      

       6.1.1 Regional Trends    

       6.1.2 Impact Analysis     

       6.1.3 Y-o-Y Growth Analysis        

                       6.1.3.1 By Method

                       6.1.3.2 By Product

                       6.1.3.3 By Application

                       6.1.3.4 By End User

       6.1.4  Market Attractiveness Analysis     

                       6.1.4.1 By Method

                       6.1.4.2 By Product

                       6.1.4.3 By Application

                       6.1.4.4 By End User

       6.1.5  Market Share Analysis      

                       6.1.5.1 By Method

                       6.1.5.2 By Product

                       6.1.5.3 By Application

                       6.1.5.4 By End User

                6.2 China    

                6.3 India     

                6.4 Japan   

                6.5 South Korea      

                6.6 Australia                      

7.Strategic Analysis               

                7.1 PESTLE analysis

       7.1.1 Political     

       7.1.2 Economic 

       7.1.3 Social         

       7.1.4 Technological         

       7.1.5 Legal          

       7.1.6 Environmental       

                7.2 Porter’s Five analysis     

       7.2.1 Bargaining Power of Suppliers        

       7.2.2 Bargaining Power of Consumers    

       7.2.3 Threat of New Entrants     

       7.2.4 Threat of Substitute Products and Services              

       7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                

                8.1 Clean Cells                  

       8.1.1 Overview 

       8.1.2 Product Analysis   

       8.1.3 Financial analysis  

       8.1.4 Recent Developments       

       8.1.5 SWOT analysis       

       8.1.6 Analyst View          

                8.2 Charles River Laboratories International Inc.                

                8.3 Danaher Corporation    

                8.4 Merck KGaA      

                8.5 Parker Hannifin

                8.6 Red Source Technologies                     

                8.7 Sartorius AG      

                8.8 SGS S.A                        

                8.9 Texcell Inc                   

                8.10 Viral Inactivated Plasma Systems SA    

                8.11 WuXi Pharma Tech Inc.                       

9.Competitive Landscape                   

                9.1 Market share analysis   

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures

                9.4 New Product Launches

10.Market Outlook and Investment Opportunities                 

Appendix                  

                a) List of Tables                

                b) List of Figures     

  1. Asia-Pacific Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  2. Asia-Pacific Solvent/Detergent method Market By Region, From 2022 to 2027 ( USD Million )
  3. Asia-Pacific Pasteurization Market By Region, From 2022 to 2027 ( USD Million )
  4. Asia-Pacific UV Radiation Market By Region, From 2022 to 2027 ( USD Million )
  5. Asia-Pacific Microwave Heating Market By Region, From 2022 to 2027 ( USD Million )
  6. Asia-Pacific High-Energy Light Market By Region, From 2022 to 2027 ( USD Million )
  7. Asia-Pacific Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  8. Asia-Pacific Services Market By Region, From 2022 to 2027 ( USD Million )
  9. Asia-Pacific Kits and Reagents Market By Region, From 2022 to 2027 ( USD Million )
  10. Asia-Pacific Accessories Market By Region, From 2022 to 2027 ( USD Million )
  11. Asia-Pacific Viral Inactivation Systems Market By Region, From 2022 to 2027 ( USD Million )
  12. Asia-Pacific Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )
  13. Asia-Pacific Vaccines and Therapeutics Market By Region, From 2022 to 2027 ( USD Million )
  14. Asia-Pacific Stem Cell Products Market By Region, From 2022 to 2027 ( USD Million )
  15. Asia-Pacific Cell Culture Market By Region, From 2022 to 2027 ( USD Million )
  16. Asia-Pacific Gene Therapy Market By Region, From 2022 to 2027 ( USD Million )
  17. Asia-Pacific Blood & Blood Products Market By Region, From 2022 to 2027 ( USD Million )
  18. Japan Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  19. Japan Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  20. Japan Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )
  21. China Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  22. China Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  23. China Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )
  24. India Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  25. India Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  26. India Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )
  27. Australia Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  28. Australia Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  29. Australia Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )
  30. South Korea Viral Inactivation Market By Method, From 2022 to 2027 ( USD Million )
  31. South Korea Viral Inactivation Market By Products, From 2022 to 2027 ( USD Million )
  32. South Korea Viral Inactivation Market By Application, From 2022 to 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample